Cargando…
Bellidifolin Inhibits SRY-Related High Mobility Group-Box Gene 9 to Block TGF-β Signalling Activation to Ameliorate Myocardial Fibrosis
Myocardial fibrosis is the main morphological change of ventricular remodelling caused by cardiovascular diseases, mainly manifested due to the excessive production of collagen proteins. SRY-related high mobility group-box gene 9 (SOX9) is a new target regulating myocardial fibrosis. Bellidifolin (B...
Autores principales: | Yao, Ting-Ting, Yang, Hong-Xia, Sun, Jia-Huan, Zhang, Yue, Zhang, Yu, Song, Qiu-Hang, Liu, Wei-Zhe, Zhang, Juan-Juan, Li, Ai-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110156/ https://www.ncbi.nlm.nih.gov/pubmed/35586685 http://dx.doi.org/10.1155/2022/6841276 |
Ejemplares similares
-
Bellidifolin Ameliorates Isoprenaline-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads and p38 Signaling and Preventing NR4A1 Cytoplasmic Localization
por: Yang, Hong-Xia, et al.
Publicado: (2021) -
Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4
por: Zhou, Dingyan, et al.
Publicado: (2023) -
Preparation, characterization and in vitro study of bellidifolin nano-micelles
por: Gao, Fan, et al.
Publicado: (2022) -
Bellidifolin Inhibits Proliferation of A549 Cells by Regulating STAT3/COX-2 Expression and Protein Activity
por: Yan, Li, et al.
Publicado: (2020) -
Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway
por: Zong, Min, et al.
Publicado: (2020)